BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2596239)

  • 1. Cytochemical detection of nickel in endometrial carcinoma during progestogen treatment.
    Patai K; Szarvas Z; Balogh I
    Acta Chir Hung; 1989; 30(3):199-204. PubMed ID: 2596239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Gestagen treatment of endometrial carcinoma].
    Seewald HJ; Böhm W
    Zentralbl Gynakol; 1974 Feb; 96(5):153-7. PubMed ID: 4133105
    [No Abstract]   [Full Text] [Related]  

  • 3. [Estrogen and progesterone receptors in endometrial carcinoma during high-dose progestogen (Depo-Provera) therapy].
    Thurzó L; Sas M; Falkay G
    Orv Hetil; 1986 Oct; 127(43):2613-6. PubMed ID: 2947029
    [No Abstract]   [Full Text] [Related]  

  • 4. [Histological changes observed in the treatment of endometrial glandular epithelioma with lynestrenol].
    Lejeune B; Wilkin P
    J Gynecol Obstet Biol Reprod (Paris); 1977 Dec; 6(8):1159-69. PubMed ID: 608932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanism of action of endocrine therapy of endometrial carcinoma].
    Kuramoto H; Hata H; Kato Y; Hata K; Hamano M; Anzai Y; Watanabe J; Holinka CF; Gurpide E
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1851-7. PubMed ID: 2730078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment with high doses of progestational agents in endometrial adenocarcinoma].
    Goisis M; Servida E; Goisis F
    Minerva Ginecol; 1976 Jan; 28(1):87-96. PubMed ID: 1256709
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effective progestogen therapy of endometrial hyperplasia and adenocarcinoma by administration of a combined progestogen-estrogen preparation].
    Miyawaki Y; Ueki M; Sugimoto O
    Nihon Gan Chiryo Gakkai Shi; 1988 Oct; 23(10):2598-605. PubMed ID: 3209928
    [No Abstract]   [Full Text] [Related]  

  • 8. [Progestational hormones in endometrial carcinoma].
    Corres Innes J; Zazueta Valadez F; Vela Lugo C
    Ginecol Obstet Mex; 1967 Sep; 22(131):1193-203. PubMed ID: 5602498
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination of progestogen therapy with the conventional treatment of endometrial carcinoma.
    Luukkainen T; Karjalainen O
    Bull Schweiz Akad Med Wiss; 1970 Oct; 25(4-6):581-5. PubMed ID: 5510182
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral progestogens and adenocarcinoma of the uterus. An account of 3 cases of advanced endometrial carcinoma treated with an oral progestogen.
    Phillips TJ
    J Obstet Gynaecol Br Commonw; 1966 Jun; 73(3):487-9. PubMed ID: 5947437
    [No Abstract]   [Full Text] [Related]  

  • 11. [Simultaneous cytofluorometric studies on DNA and protein in endometrial adenocarcinoma--with reference to gestagen treatment].
    Ohta T
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 May; 38(5):750-8. PubMed ID: 3722954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gestagen treatment of endometrial carcinoma--theoretical and practical application].
    Sugawa T; Sako H
    Gan To Kagaku Ryoho; 1984 May; 11(5):1005-11. PubMed ID: 6721511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ineffectiveness of tamoxifen in advanced endometrial carcinoma after failure of progestin treatment.
    Edmonson JH; Krook JE; Hilton JF; Long HJ; Cullinan SA; Everson LK; Malkasian GD
    Cancer Treat Rep; 1986 Aug; 70(8):1019-20. PubMed ID: 3731147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preliminary note on histologic changes induced by a new synthetic gestagen (19-nor-17-alpha-hydroxyprogesterone capronate) on adenocarcinoma of the endometrium].
    Vecchione A; Ruozi Berretta L
    Riv Anat Patol Oncol; 1968; 33():431-60. PubMed ID: 5760166
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulation of estrogen receptor levels in endometrial cancer cells.
    Gurpide E; Blumenthal R; Fleming H
    Prog Clin Biol Res; 1984; 142():145-65. PubMed ID: 6709655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of an estrogen-regulated protein in endometrial cancer.
    Sledge GW; Ramzy I; Dressler LG; Dorr FA; Adams DJ; McGuire WL
    Obstet Gynecol; 1985 Sep; 66(3):423-7. PubMed ID: 3895080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Histopathological changes in endometrial cancer treated with tamoxifen].
    Lin HH; Ueda K; Kato J
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1038-43. PubMed ID: 3963849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progestogen in recurrenct endometrial carcinoma.
    Mehta A; Shroff M
    Indian J Cancer; 1966 Dec; 3(4):305-9. PubMed ID: 5977884
    [No Abstract]   [Full Text] [Related]  

  • 19. Estrogen receptors in human uterine adenocarcinoma: correlation with tissue differentiation, vaginal karyopycnotic index, and effect of progestogen or anti-estrogen treatment.
    Billiet G; De Hertogh R; Bonte J; Ide P; Vlaemynck G
    Gynecol Oncol; 1982 Aug; 14(1):33-9. PubMed ID: 6212297
    [No Abstract]   [Full Text] [Related]  

  • 20. [Correlation between estrogen receptor(ER), progesterone receptor(PR) and human keratin protein (hKP) in endometrial carcinoma].
    Hatae M; Yagi Y
    Gan No Rinsho; 1983 Dec; 29(15):1740-9. PubMed ID: 6199529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.